Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-26

Clinical Trial Update: Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating two doses of oral HDV-Insulin versus placebo with metformin in type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HDV insulin (HDV insulin)

Snippet

Sponsor: Diasome Pharmaceuticals | Conditions: Diabetes | Phase 2, Phase 3 | Status: COMPLETED